FAIRFIELD, Iowa, February 27, 2017 — Hedge funds were up 1.35% in January according to the Barclay Hedge Fund Index compiled by BarclayHedge.
All but two of Barclay’s 17 hedge fund indices gained ground in January. Emerging Markets got off to a fast start in 2017 with a 2.63% gain, Technology was up 2.57%, Healthcare and Biotechnology gained 2.22%, the Event Driven Index added 2.08%, and Distressed Securities were up 1.78%.
“A global stock market rally pushed US equity prices to new all-time highs — again, as the promise of tax cuts and fiscal stimulus fueled investor confidence and provided an ample tailwind for a profitable month,” says Sol Waksman, founder and president of BarclayHedge.
The only losing hedge fund strategies in January were Merger Arbitrage, which was down 0.38% and Global Macro which slipped 0.02%.
Looking back at 2016, the Barclay Hedge Fund Index was up for the fifth year in a row, with a total gain of 6.09%. The Index has recorded positive returns in 18 of the past 20 years, with one-year losses occurring only in 2008 and 2011.
The Barclay Fund of Funds Index gained 0.89% in January.
Click here to view five years of Barclay Hedge Fund Index data, or to download 20 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email email@example.com.
BarclayHedge is the global leader in providing independent, research-based information services to the alternative investment industry. Founded in 1985, Barclay currently maintains data on more than 6,400 hedge funds, fund of funds, and CTAs. No one has been in the business of collecting alternative investment data longer than BarclayHedge.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.